Skip to content

The kinase CK1α coordinates the initiation and termination of the cGAS-STING pathway.

Aug 2026 · Cell Death and Differentiation · 0 citations · 78 references
Medicine

TL;DR

It is reported that Casein Kinase 1 alpha operates as a bimodal regulator of the cGAS-STING pathway, and selective degradation of CK1α using molecular-glue degraders suppressed aberrant cGAS-STING-driven inflammation signaling in a chromosomally unstable triple-negative breast cancer cell line.

View source

Similar papers

Review Open access Aug 2026

The cGAS/STING pathway in cancer: translating innate DNA sensing into therapeutic potential

How context determines the consequences of cGAS/STING activation in cancer is examined, emerging therapeutic strategies that modulate this pathway are reviewed, and how its antitumor potential can be maximized while minimizing systemic toxicity and immune dysregulation is discussed.

Yi Wang, J. Angulo-Lozano, Yue-Qi Wang et al. · 0 citations
Review Open access Aug 2026

cGAS-STING pathway activation drives the cold-to-hot tumor transition and sensitizes immunotherapy.

A detailed understanding of the cGAS-STING axis has substantial value in providing theoretical guidance and supporting clinical translation in the development of next-generation combination immunotherapies, as well as broadening the patient population benefiting from clinical interventions.

Xin-Ru Zhao, Shuai Meng, Hanzeng Cheng et al. · 0 citations
Review Open access Aug 2026

The Significance of cGAS‐STING Signaling in Response to Oncogenic Viruses

ABSTRACT The cyclic GMP‐AMP synthase (cGAS)‐stimulator of interferon genes (STING) signaling pathway, as a key DNA sensor, plays a significant role in the regulation of innate immune responses. This pathway can be activated by sensing abnormal DNA, and is of great significance for resisting the invasion of pathogenic microorganisms and maintaining tissue homeostasis. In addition, the cGAS‐STING pathway plays a dual role in cancer, and oncogenic viruses can cause cell carcinogenesis in the body through multiple mechanisms, thereby affecting human health. This manuscript reviews the vital role of cGAS‐STING in the immune process, as well as the fact that viruses causing human tumor lesions can activate cGAS‐STING, leading to virus inhibition and further preventing the occurrence and development of related cancers, and the paradoxically promoted progression of related cancers by viruses through cGAS‐STING. And summarize the agonists and inhibitors that act in different ways based on the activation mechanism of cGAS‐STING.

Li-Mei Guo, Li Li, Fang Wang et al. · 0 citations
Review Aug 2026

The cGAS-STING pathway and its functions in immune defense and inflammatory regulation in teleost fish.

Cyclic GMP-AMP synthase (cGAS) could recognize double-stranded DNA in the cytoplasm and catalyze the synthesis of cyclic GMP-AMP (cGAMP). This molecule activates the endoplasmic reticulum-resident protein stimulator of interferon genes (STING), thereby initiating the TBK1 (TANK-binding kinase 1)-IRF3 (interferon regulatory factor 3) signal cascade and promoting the expression of type I interferons and various inflammatory factors. The cGAS-STING pathway serves as a fundamental signal axis for DNA recognition in the cytoplasm of vertebrates and is crucial for innate immune defense. Recent research on the cGAS-STING pathway in fish has gradually advanced, with gene cloning and analyses completed across various fish species, indicating that this pathway plays a significant role in antiviral responses in fish. However, compared to mammals, the cGAS-STING pathway exhibits relative deficiencies in molecular regulatory mechanisms, structural analyses, and in vivo functional validations in different aquatic animals. Teleost fish occupy a critical stage in vertebrate evolution. The cGAS-STING pathway in teleost fish is systematically summarized to enhance our comprehensive understanding for the innate immune regulatory network, and the potential molecular targets is to be identified for disease-resistant breeding, immune enhancement, and sustainable aquaculture practices.

Qi-Yang Wang, Xiuying Cui, Mi-Tong Guo et al. · 0 citations
Open access Sep 2026

Precision tuning of STING signaling: a mutational blueprint

In a recent publication in Nature , Zhang et al. present a comprehensive functional atlas of stimulator of interferon genes (STING), a central adaptor of innate immunity. 1 By systematically interrogating thousands of single amino-acid substitutions, the study reveals how distinct structural regions of STING collectively regulate interferon induction, NF-κ B activation and non-canonical autophagy. The work provides a new molecular framework for understanding STING activation, disease-associated variants and future therapeutic modulation of this pathway. STING occupies a central position in innate immune sensing. It functions as the central adaptor downstream of cyclic GMP – AMP synthase (cGAS), which detects cytosolic DNA and generates the second messenger 2 ′ 3 ′ -cGAMP. Binding of 2 ′ 3 ′ -cGAMP induces large conformational rearrangements, oligomerization and traf-fi cking from the endoplasmic reticulum to Golgi and post-Golgi compartments. These events trigger recruitment and activation of TBK1, leading to phosphorylation of IRF3, resulting in type I interferon production, and also promote NF-κ B-dependent in fl ammatory responses. In parallel, STING can induce a non-canonical form of autophagy, linked to LC3B lipidation and, as recently shown, proton-channel activity in post-Golgi membranes. 2 – 4 Through these outputs, STING contributes to host defense against infection, immune surveillance of cancer, cellular senescence and in fl ammatory disease. Its central position has made STING an attractive therapeutic target, with efforts directed both toward agonists, for cancer immunotherapy and vaccine adjuvanticity, and antagonists, for interferonopathies and other in fl ammatory conditions. Yet STING signaling is not a simple on – off switch. It involves ligand binding, conformational transition

A. Cuapio, Hans-Gustaf Ljunggren · 0 citations
Jul 2026

Abstract B045: Targeted degradation of cyclin T1 constrains transcription elongation and triggers tumour cell apoptosis

It is demonstrated that selective degradation of CCNT1 can effectively collapse pTEFb-dependent transcriptional programmes and compromise tumour cell fitness, which may offer a more selective and durable route for therapeutic intervention in transcriptionally dependent tumours.

Janice Wenzheng Neng, Laura Blenkarn, Laura S. Itzhaki et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.